Dai-ichi Life Insurance Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.1M Sell
326,922
-25,993
-7% -$2.79M 0.99% 17
2025
Q1
$35.6M Sell
352,915
-38,889
-10% -$3.92M 1.04% 16
2024
Q4
$35M Buy
391,804
+13,136
+3% +$1.17M 0.97% 19
2024
Q3
$31.7M Buy
378,668
+59,330
+19% +$4.97M 0.8% 23
2024
Q2
$24.6M Buy
319,338
+28,247
+10% +$2.18M 0.6% 40
2024
Q1
$19.9M Sell
291,091
-26,358
-8% -$1.81M 0.45% 48
2023
Q4
$18.4M Buy
317,449
+31,572
+11% +$1.83M 0.38% 60
2023
Q3
$15.1M Buy
285,877
+12,804
+5% +$676K 0.33% 67
2023
Q2
$14.8M Sell
273,073
-43,865
-14% -$2.37M 0.31% 68
2023
Q1
$15.9M Sell
316,938
-4,409
-1% -$221K 0.35% 64
2022
Q4
$14.9M Buy
321,347
+102,608
+47% +$4.75M 0.34% 59
2022
Q3
$8.47M Buy
218,739
+25,792
+13% +$999K 0.21% 98
2022
Q2
$7.19M Buy
192,947
+94,157
+95% +$3.51M 0.16% 125
2022
Q1
$4.38M Sell
98,790
-4,119
-4% -$182K 0.07% 221
2021
Q4
$4.37M Sell
102,909
-2,439
-2% -$104K 0.06% 240
2021
Q3
$4.57M Sell
105,348
-5,831
-5% -$253K 0.06% 222
2021
Q2
$4.75M Sell
111,179
-87,969
-44% -$3.76M 0.06% 225
2021
Q1
$7.7M Sell
199,148
-2,458
-1% -$95K 0.11% 163
2020
Q4
$7.25M Buy
201,606
+18,553
+10% +$667K 0.1% 158
2020
Q3
$6.99M Buy
183,053
+47,455
+35% +$1.81M 0.13% 134
2020
Q2
$4.76M Sell
135,598
-2,649
-2% -$93K 0.11% 146
2020
Q1
$4.51M Buy
138,247
+22,217
+19% +$725K 0.17% 136
2019
Q4
$5.25M Buy
116,030
+1,344
+1% +$60.8K 0.12% 182
2019
Q3
$4.67M Hold
114,686
0.11% 198
2019
Q2
$4.93M Sell
114,686
-27,599
-19% -$1.19M 0.12% 184
2019
Q1
$5.46M Sell
142,285
-1,694
-1% -$65K 0.13% 168
2018
Q4
$5.09M Sell
143,979
-238
-0.2% -$8.41K 0.14% 171
2018
Q3
$5.55M Buy
144,217
+28,794
+25% +$1.11M 0.12% 176
2018
Q2
$3.77M Sell
115,423
-16,065
-12% -$525K 0.09% 228
2018
Q1
$3.59M Buy
131,488
+50,000
+61% +$1.37M 0.07% 235
2017
Q4
$2.02M Hold
81,488
0.04% 310
2017
Q3
$2.38M Hold
81,488
0.05% 298
2017
Q2
$2.26M Buy
81,488
+17,180
+27% +$476K 0.05% 295
2017
Q1
$1.6M Sell
64,308
-180,000
-74% -$4.48M 0.04% 315
2016
Q4
$5.28M Buy
+244,308
New +$5.28M 0.16% 164